News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medican Is In Negotiations To Obtain 51% Of IHMML


6/30/2014 11:34:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd (“IHMML”). Medican previously announced that they signed an agreement to obtain 50% of IHMML, but for consolidation purposes and increasing role undertaken by the IHMML management team, we are finalizing terms for a 51% acquisition. This will give Medican a controlling interest in IHMML and fits in well with our long-term vision to become a leader in the medical marijuana space.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES